ANJAC Health & Beauty Strengthens Its Presence in North America and Its Pharmaceutical Activities with the Acquisition of Pillar5 Pharma

Jennifer E. Engen

PARIS, March 14, 2022–(BUSINESS WIRE)–Today ANJAC Health & Beauty (ANJAC) announced its acquisition of Pillar5 Pharma (Pillar5), one of the primary manufacturers (CDMOs) specializing in the production of sterile ophthalmic solutions and niche solid dose manufacturing (tablets, capsules etc.). The acquisition reinforces ANJAC’s international expansion and broadens its health offerings […]